The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis.
In: Artificial Cells, Nanomedicine & Biotechnology, Jg. 51 (2023-12-01), Heft 1, S. 217-232
Online
academicJournal
Zugriff:
We comprised metabolites of gut microbiota (GM; endogenous species) and dietary plant-derived natural flavonoids (DPDNFs; exogenous species) were known as potent effectors against non-alcoholic fatty liver disease (NAFLD) via network pharmacology (NP). The crucial targets against NAFLD were identified via GM and DPDNFs. The protein interaction (PPI), bubble chart and networks of GM or natural products-metabolites-targets-key signalling (GNMTK) pathway were described via R Package. Furthermore, the molecular docking test (MDT) to verify the affinity was performed between metabolite(s) and target(s) on a key signalling pathway. On the networks of GNMTK, Enterococcus sp. 45, Escherichia sp.12, Escherichia sp.33 and Bacterium MRG-PMF-1 as key microbiota; flavonoid-rich products as key natural resources; luteolin and myricetin as key metabolites (or dietary flavonoids); AKT Serine/Threonine Kinase 1 (AKT1), CF Transmembrane conductance Regulator (CFTR) and PhosphoInositide-3-Kinase, Regulatory subunit 1 (PIK3R1) as key targets are promising components to treat NAFLD, by suppressing cyclic Adenosine MonoPhosphate (cAMP) signalling pathway. This study shows that components (microbiota, metabolites, targets and a key signalling pathway) and DPDNFs can exert combinatorial pharmacological effects against NAFLD. Overall, the integrated pharmacological approach sheds light on the relationships between GM and DPDNFs. [ABSTRACT FROM AUTHOR]
Copyright of Artificial Cells, Nanomedicine & Biotechnology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis.
|
---|---|
Autor/in / Beteiligte Person: | Oh, Ki-Kwang ; Gupta, Haripriya ; Ganesan, Raja ; Sharma, Satya Priya ; Won, Sung-Min ; Jeong, Jin-Ju ; Lee, Su-Been ; Cha, Min-Gi ; Kwon, Goo-Hyun ; Jeong, Min-Kyo ; Min, Byeong-Hyun ; Hyun, Ji-Ye ; Eom, Jung-A ; Park, Hee-Jin ; Yoon, Sang-Jun ; Choi, Mi-Ran ; Dong Joon Kim ; Suk, Ki-Tae |
Link: | |
Zeitschrift: | Artificial Cells, Nanomedicine & Biotechnology, Jg. 51 (2023-12-01), Heft 1, S. 217-232 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 2169-1401 (print) |
DOI: | 10.1080/21691401.2023.2203734 |
Schlagwort: |
|
Sonstiges: |
|